Debt-to-equity of REGENEREX PHARMA, INC. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
REGENEREX PHARMA, INC. quarterly Debt-to-equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • REGENEREX PHARMA, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -118%, a 0.26% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

REGENEREX PHARMA, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -118% 0% -0.26% 30 Sep 2025
Q2 2025 -118% +3% +2.3% 30 Jun 2025
Q1 2025 -118% +10% +8.2% 31 Mar 2025
Q4 2024 -115% +14% +11% 31 Dec 2024
Q3 2024 -118% +11% +8.7% 30 Sep 2024
Q2 2024 -121% +4% +3.2% 30 Jun 2024
Q1 2024 -128% -28% -27% 31 Mar 2024
Q4 2023 -129% -28% -28% 31 Dec 2023
Q3 2023 -129% -28% -27% 30 Sep 2023
Q2 2023 -125% -23% -23% 30 Jun 2023
Q1 2023 -101% +1% +0.5% 31 Mar 2023
Q4 2022 -101% 0% +0.18% 31 Dec 2022
Q3 2022 -101% +8% +7.2% 30 Sep 2022
Q2 2022 -101% +18% +15% 30 Jun 2022
Q1 2022 -101% +31% +23% 31 Mar 2022
Q4 2021 -101% +49% +33% 31 Dec 2021
Q3 2021 -109% +44% +29% 30 Sep 2021
Q2 2021 -119% +37% +24% 30 Jun 2021
Q1 2021 -132% +20% +13% 31 Mar 2021
Q4 2020 -150% -4% -2.6% 31 Dec 2020
Q3 2020 -153% 30 Sep 2020
Q2 2020 -156% 30 Jun 2020
Q1 2020 -152% 31 Mar 2020
Q4 2019 -146% 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.